Trial Search Results
Autologous Regenerative Technology (ART) For Wound Healing
The purpose of the study is to provide a more effective method of harvesting skin with minimal or no pain, heal more rapidly with little scarring in an outpatient setting with the use of only local anesthesia.
Stanford is currently accepting patients for this trial.
- Device: Autologous Regenerative Technology (ART)
- Any age ranging 18-90, any gender or ethnic background is a candidate.
- Subjects with chronic wounds that have been present for at least 4 weeks
- Pregnant women.
- Adults unable to consent.
- Subjects requiring concurrent systemic antimicrobials during the study period for any
- Subjects with leg lesions and clinically significant and unreconstructed peripheral
- Subjects who are receiving immunosuppressive agents, radiation therapy, or cytotoxic
- Subjects who require treatment for a primary or metastatic malignancy (other than
squamous or basal cell carcinoma of the skin).
- Subjects with other conditions considered by the investigator to be reasons for
disqualification that may jeopardize subject safety or interfere with the objectives
of the trial (e.g., acute illness or exacerbation of chronic illness, lack of
motivation, history of poor compliance).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study